India Diabetes Management Devices Market Forecast and Opportunities, 2020
In 2014, India had the second largest number of diabetic patients, globally. Hence, in order to constrain spiraling healthcare costs and limit the progression of Type 2 diabetes and its complications, development of affordable and effective diabetes management devices has become a top priority for India. Diabetes management devices, such as self-monitoring glucometer, Hb1Ac Analyser, urine glucose monitoring strip, continuous glucose monitoring devices, etc., are used to monitor and control the glucose level in the blood. Number of diabetic patients in India is increasing at a robust pace on account of growing obese population, sedentary lifestyle, unhealthy diet and high stress levels. Further, the number of diabetic patients in the country is anticipated to increase as a large proportion of the population is pre-diabetic, which may join the pool during forecast period.
According to Pharmaion report, “India Diabetes Management Devices Market Forecast & Opportunities, 2020”, diabetes management devices market in India is projected to exhibit a CAGR of over 9% during 2015 – 2020. Growth in the market is anticipated on account of increasing diabetic population, growing research on diabetes & its management and ongoing introduction of various technologically advanced devices. Moreover, new and improved diabetes administration devices, such as insulin pens, insulin pumps, insulin pen injectors, etc., are enabling portable, less costly, easy-to-use, accurate and virtually painless injection of insulin, thereby boosting the sales of diabetes management devices in India. On the basis of type, the market has been segmented into two broad categories, namely, diabetes monitoring devices and diabetes management delivery devices. Among these two categories, diabetes monitoring devices is anticipated to continue its domination through 2020 on account of rising patient awareness regarding preventive health care and introduction of compact, potable and user friendly technologically advanced devices. Few of the leading companies operating in diabetes management devices market in India include Roche, LifeScan, Abbott, Bayer, Arkay, and Medtronic, among others. “India Diabetes Management Devices Market & Opportunities, 2020” elaborates the following aspects of diabetes management devices market in India:
The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with diabetes management devices manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.
According to Pharmaion report, “India Diabetes Management Devices Market Forecast & Opportunities, 2020”, diabetes management devices market in India is projected to exhibit a CAGR of over 9% during 2015 – 2020. Growth in the market is anticipated on account of increasing diabetic population, growing research on diabetes & its management and ongoing introduction of various technologically advanced devices. Moreover, new and improved diabetes administration devices, such as insulin pens, insulin pumps, insulin pen injectors, etc., are enabling portable, less costly, easy-to-use, accurate and virtually painless injection of insulin, thereby boosting the sales of diabetes management devices in India. On the basis of type, the market has been segmented into two broad categories, namely, diabetes monitoring devices and diabetes management delivery devices. Among these two categories, diabetes monitoring devices is anticipated to continue its domination through 2020 on account of rising patient awareness regarding preventive health care and introduction of compact, potable and user friendly technologically advanced devices. Few of the leading companies operating in diabetes management devices market in India include Roche, LifeScan, Abbott, Bayer, Arkay, and Medtronic, among others. “India Diabetes Management Devices Market & Opportunities, 2020” elaborates the following aspects of diabetes management devices market in India:
- India Diabetes Management Devices Plastic Market Size, Share & Forecast
- Segmental Analysis – Diabetes Monitoring Devices and Diabetes Management Delivery Devices
- Policy & Regulatory Landscape
- Changing Market Trends & Emerging Opportunities
- Competitive Landscape & Strategic Recommendations
- To gain an in-depth understanding of diabetes management devices market in India
- To identify the on-going trends and anticipated growth in the next five years
- To help industry consultants, device manufacturers, vendors and dealers align their market-centric strategies
- To obtain research based business decisions and add weight to presentations and marketing material
- To gain competitive knowledge of leading market players
- To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer’s specific needs
The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with diabetes management devices manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.
1. RESEARCH METHODOLOGY
2. ANALYST VIEW
3. DIABETES MANAGEMENT DEVICE OVERVIEW
4. DISEASE EPIDEMIOLOGY
5. GLOBAL DIABETES MANAGEMENT DEVICE MARKET OVERVIEW
6. INDIA DIABETES MANAGEMENT DEVICE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End User
6.2.3. By Region
6.2.4. By Company
7. INDIA DIABETES MONITORING DEVICE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Components/ Devices
7.2.2. By End User
8. INDIA DIABETES MANAGEMENT DELIVERY DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
10.1. Insulin Spray
10.2. Remote Diabetes Monitoring Device
10.3. Health App
10.4. Continuous Glucose Monitoring Device
10.5. Non Invasive/ Wearable Devices
11. POLICY & REGULATORY LANDSCAPE
12. INDIA ECONOMIC PROFILE
13. COMPETITIVE LANDSCAPE
13.1. Competition Benchmarking (Market Attractiveness)
13.2. Company Profiles
13.2.1. Roche Diagnostics India Pvt. Ltd.
13.2.2. LifeScan India
13.2.3. Abbott India Limited
13.2.4. Bayer Healthcare
13.2.5. India Medtronic Pvt. Ltd.
13.2.6. ARKRAY Healthcare Pvt Ltd.
13.2.7. Eli lily And Company (India) Pvt Ltd
13.2.8. Sanofi India Limited
13.2.9. Novo Nordisk India
13.2.10. Biocon Limited
14. STRATEGIC RECOMMENDATIONS
2. ANALYST VIEW
3. DIABETES MANAGEMENT DEVICE OVERVIEW
4. DISEASE EPIDEMIOLOGY
5. GLOBAL DIABETES MANAGEMENT DEVICE MARKET OVERVIEW
6. INDIA DIABETES MANAGEMENT DEVICE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End User
6.2.3. By Region
6.2.4. By Company
7. INDIA DIABETES MONITORING DEVICE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Components/ Devices
7.2.2. By End User
8. INDIA DIABETES MANAGEMENT DELIVERY DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
10.1. Insulin Spray
10.2. Remote Diabetes Monitoring Device
10.3. Health App
10.4. Continuous Glucose Monitoring Device
10.5. Non Invasive/ Wearable Devices
11. POLICY & REGULATORY LANDSCAPE
12. INDIA ECONOMIC PROFILE
13. COMPETITIVE LANDSCAPE
13.1. Competition Benchmarking (Market Attractiveness)
13.2. Company Profiles
13.2.1. Roche Diagnostics India Pvt. Ltd.
13.2.2. LifeScan India
13.2.3. Abbott India Limited
13.2.4. Bayer Healthcare
13.2.5. India Medtronic Pvt. Ltd.
13.2.6. ARKRAY Healthcare Pvt Ltd.
13.2.7. Eli lily And Company (India) Pvt Ltd
13.2.8. Sanofi India Limited
13.2.9. Novo Nordisk India
13.2.10. Biocon Limited
14. STRATEGIC RECOMMENDATIONS
LIST OF TABLES
Table 1: Statistics of Diabetes in India, 2013
Table 2: Partial List of Diabetes Prevalence in India, By State
Table 3: Partial Diabetes Management Devices Product Portfolio in India
Table 4: India Diabetes Monitoring Devices Average Cost (USD), 2014
Table 5: India Diabetes Management Delivery Devices Average Cost (USD), 2014
Table 6: List of Some Android/ iOS Diabetes Health Apps in India
Table 1: Statistics of Diabetes in India, 2013
Table 2: Partial List of Diabetes Prevalence in India, By State
Table 3: Partial Diabetes Management Devices Product Portfolio in India
Table 4: India Diabetes Monitoring Devices Average Cost (USD), 2014
Table 5: India Diabetes Management Delivery Devices Average Cost (USD), 2014
Table 6: List of Some Android/ iOS Diabetes Health Apps in India
LIST OF FIGURES
Figure 1: Number of Diabetic Patients (20-79 years) in India, 2014
Figure 2: Number of Diabetic Patients (20-79 years) in Urban and Rural India, 2014
Figure 3: Disease Burden Indicators for Top Diabetic Countries, 2014
Figure 4: India Diabetes Management Devices Market Size, By Value (USD Million), 2010-2020F
Figure 5: India Diabetes Management Devices Market Share, By Type, By Value, 2010-2020F
Figure 6: India Diabetes Management Devices Market Share, By End User, By Value, 2010-2020F
Figure 7: India Diabetes Management Devices Market Share, By Region, By Value, 2010-2020F
Figure 8: India Diabetes Management Devices Market Share, By Region, By Value, 2010-2020F
Figure 9: India Diabetes Management Devices Market Share, By Value, By Company, 2014
Figure 10: India Diabetes Management Devices Market Share, By Value, By Company, 2020F
Figure 11: India Diabetes Monitoring Devices Market Size, By Value, 2010-2020F (USD Million)
Figure 12: India Diabetes Monitoring Devices Market Share, By Value, By Components/ Devices, 2010-2020F
Figure 13: India Diabetes Monitoring Devices Market Share, By Value, By End User, 2010-2020F
Figure 14: India Diabetes Management Delivery Devices Market Size, By Value, 2010-2020F (USD Million)
Figure 15: India Diabetes Management Delivery Devices Market Size, By Value, By Type, 2010-2020F (USD Million)
Figure 16: India Diabetes Management Delivery Devices Market Size, By Value, By End-Use, 2010-2020F (USD Million)
Figure 17: India Diabetic Population, 2011, 2014 & 2030F (Million)
COMPANIES MENTIONED
1. Roche Diagnostics India Pvt. Ltd.
2. LifeScan India
3. Abbott India Limited
4. Bayer Healthcare
5. India Medtronic Pvt. Ltd.
6. ARKRAY Healthcare Pvt Ltd.
7. Eli lily And Company (India) Pvt Ltd
8. Sanofi India Limited
9. Novo Nordisk India
10. Biocon Limited
Figure 1: Number of Diabetic Patients (20-79 years) in India, 2014
Figure 2: Number of Diabetic Patients (20-79 years) in Urban and Rural India, 2014
Figure 3: Disease Burden Indicators for Top Diabetic Countries, 2014
Figure 4: India Diabetes Management Devices Market Size, By Value (USD Million), 2010-2020F
Figure 5: India Diabetes Management Devices Market Share, By Type, By Value, 2010-2020F
Figure 6: India Diabetes Management Devices Market Share, By End User, By Value, 2010-2020F
Figure 7: India Diabetes Management Devices Market Share, By Region, By Value, 2010-2020F
Figure 8: India Diabetes Management Devices Market Share, By Region, By Value, 2010-2020F
Figure 9: India Diabetes Management Devices Market Share, By Value, By Company, 2014
Figure 10: India Diabetes Management Devices Market Share, By Value, By Company, 2020F
Figure 11: India Diabetes Monitoring Devices Market Size, By Value, 2010-2020F (USD Million)
Figure 12: India Diabetes Monitoring Devices Market Share, By Value, By Components/ Devices, 2010-2020F
Figure 13: India Diabetes Monitoring Devices Market Share, By Value, By End User, 2010-2020F
Figure 14: India Diabetes Management Delivery Devices Market Size, By Value, 2010-2020F (USD Million)
Figure 15: India Diabetes Management Delivery Devices Market Size, By Value, By Type, 2010-2020F (USD Million)
Figure 16: India Diabetes Management Delivery Devices Market Size, By Value, By End-Use, 2010-2020F (USD Million)
Figure 17: India Diabetic Population, 2011, 2014 & 2030F (Million)
COMPANIES MENTIONED
1. Roche Diagnostics India Pvt. Ltd.
2. LifeScan India
3. Abbott India Limited
4. Bayer Healthcare
5. India Medtronic Pvt. Ltd.
6. ARKRAY Healthcare Pvt Ltd.
7. Eli lily And Company (India) Pvt Ltd
8. Sanofi India Limited
9. Novo Nordisk India
10. Biocon Limited
